Pfizer hypes Advil line extension with TV ad, personal shopper offer

Share this article:
Pfizer hypes Advil line extension with TV ad, personal shopper offer
Pfizer hypes Advil line extension with TV ad, personal shopper offer
Pfizer Consumer Healthcare is launching an Advil line extension with a contest to win a personal shopper for “Black Friday,” the Friday after Thanksgiving, when bargain-hunting holiday shoppers pack stores.

Pfizer is hawking Advil Congestion Relief, a new Advil-plus-decongestant formula that promises to alleviate sinus pressure by easing nasal inflammation. The company is also airing TV ads by ghg titled “Don't blame mucus.” The message: snot's not the problem – inflammation is, as a man in a green shirt that reads “Mucus” attests. Advil, he says, is “The right sinus medicine for the real problem.”

Mr. Mucus, the star of Reckitt Benckiser's Mucinex campaign, will doubtless feel vindicated.

For the Black Friday campaign, shoppers at malls in the Jersey City, Atlanta, Chicago, Dallas and San Francisco areas can text for a chance to win a “personal Black Friday Decongester” who will help a hundred of them avoid congested stores. One grand prize winner in each market will also win a $1,000 gift card.

Pfizer flagged a recent poll that found around 70% of Americans avoid crowded or congested areas during the holidays.

Ketchum is handling PR for the Decongester campaign.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

New lipid agents are high on potency, low on doc awareness

New lipid agents are high on potency, low ...

The new PCSK9 class of cholesterol-lowering antibodies continues to look promising, but many doctors—particularly PCPs—have never even heard of the experimental drugs.

Novartis may have game-changing drug

Novartis may have game-changing drug

Key opinion leaders indicate they are ready to embrace Novartis's experimental heart failure medication LCZ696. Such a move could upend heart failure treatment protocols.

Five things for pharma marketers to know: Tuesday, September 2

Five things for pharma marketers to know: Tuesday, ...

Sanofi and Regeneron unveil Phase-III results of their PCSK9; Merck will present data on its anti-PD-1 at the end of this month; WSJ op/ed suggests US should lead fight against ...